Cargando…

Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes

Adoptive immunotherapy with Tregs is a promising approach for prevention or treatment of type 1 diabetes. Islet antigen-specific Tregs have more potent therapeutic effects than polyclonal cells, but their low frequency is a barrier for clinical application. To generate Tregs that recognize islet ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spanier, Justin A., Fung, Vivian, Wardell, Christine M., Alkhatib, Mohannad H., Chen, Yixin, Swanson, Linnea A., Dwyer, Alexander J., Weno, Matthew E., Silva, Nubia, Mitchell, Jason S., Orban, Paul C., Mojibian, Majid, Verchere, C. Bruce, Fife, Brian T., Levings, Megan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980092/ https://www.ncbi.nlm.nih.gov/pubmed/36865264 http://dx.doi.org/10.1101/2023.02.23.529737

Ejemplares similares

Tregs with an MHC class II peptide–specific chimeric antigen receptor prevent autoimmune diabetes in mice
por: Spanier, Justin A., et al.
Publicado: (2023)

Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
por: Rosado-Sánchez, Isaac, et al.
Publicado: (2023)

Enhanced CD4(+) and CD8(+) T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses
por: Dwyer, Alexander J., et al.
Publicado: (2021)

T reg–specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome
por: Wu, Dan, et al.
Publicado: (2020)

Human A2-CAR T cells reject HLA-A2+ human islets transplanted into mice without inducing graft versus host disease
por: Ellis, Cara E., et al.
Publicado: (2023)

Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance
por: Kaljanac, Marcell, et al.
Publicado: (2022)

Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation
por: Pathak, Shiva, et al.
Publicado: (2021)

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
por: Proics, Emma, et al.
Publicado: (2022)

Treg-Therapy Allows Mixed Chimerism and Transplantation Tolerance Without Cytoreductive Conditioning
por: Pilat, N, et al.
Publicado: (2010)

Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
por: Zhang, Qunfang, et al.
Publicado: (2018)

Decoupling peptide binding from T cell receptor recognition with engineered chimeric MHC-I molecules
por: Papadaki, Georgia F., et al.
Publicado: (2023)

Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells
por: Chmielewski, Markus, et al.
Publicado: (2013)

MHC-mismatched mixed chimerism restores peripheral tolerance of noncross-reactive autoreactive T cells in NOD mice
por: Zhang, Mingfeng, et al.
Publicado: (2018)

Diverse Hematological Malignancies Including Hodgkin-Like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice
por: Raffegerst, Silke H., et al.
Publicado: (2009)

An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
por: Maus, Marcela V, et al.
Publicado: (2017)

Tolerance of a Vascularized Composite Allograft Achieved in MHC Class-I-mismatch Swine via Mixed Chimerism
por: Lellouch, Alexandre G., et al.
Publicado: (2022)

Genetic engineering of human and mouse CD4(+) and CD8(+) Tregs using lentiviral vectors encoding chimeric antigen receptors
por: Vimond, Nadège, et al.
Publicado: (2020)

A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse
por: Wang, Stacie Shiqi, et al.
Publicado: (2021)

AAV8 Ins1-Cre can produce efficient β-cell recombination but requires consideration of off-target effects
por: Ramzy, Adam, et al.
Publicado: (2020)

Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
por: Lamarche, Caroline, et al.
Publicado: (2023)

Induction of stable human FOXP3(+) Tregs by a parasite‐derived TGF‐β mimic
por: Cook, Laura, et al.
Publicado: (2021)

MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway
por: Wilson, Kayla R., et al.
Publicado: (2018)

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
por: Seif, Farhad, et al.
Publicado: (2023)

The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model
por: Timrott, Kai, et al.
Publicado: (2020)

Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD
por: Jin, Yang, et al.
Publicado: (2014)

Pathological conditions re-shape physiological Tregs into pathological Tregs
por: Yang, William Y, et al.
Publicado: (2015)

ICOS(+) Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2020)

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies
por: Li, Demin, et al.
Publicado: (2017)

Strategies for optimizing CITE-seq for human islets and other tissues
por: Colpitts, Sarah J., et al.
Publicado: (2023)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
por: Zou, Yixin, et al.
Publicado: (2018)

Developmental Timing of High-Fat Diet Exposure Impacts Glucose Homeostasis in Mice in a Sex-Specific Manner
por: Glavas, Maria M., et al.
Publicado: (2021)

Human CD25(+)CD4(+) T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells
por: Levings, Megan K., et al.
Publicado: (2002)

Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127(pos) Depletion, Treg Expansion, and Treg Cryopreservation
por: Peters, Jorieke H., et al.
Publicado: (2008)

Corrigendum: ICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
por: Li, Dan-Yang, et al.
Publicado: (2021)

MON-LB033 Unleashing the Anti-Inflammatory Potential of Treg Cells Against Type I Diabetes Using Advanced Chimeric Antigen Receptor Technology
por: Imam, Shahnawaz, et al.
Publicado: (2019)

Induction of Mixed Chimerism With MHC-Mismatched but Not Matched Bone Marrow Transplants Results in Thymic Deletion of Host-Type Autoreactive T-Cells in NOD Mice
por: Racine, Jeremy, et al.
Publicado: (2011)

Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs
por: Wienke, Judith, et al.
Publicado: (2020)

Engineering the gut for insulin replacement to treat diabetes
por: Mojibian, Majid, et al.
Publicado: (2016)

Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers
por: Izquierdo, Cristina, et al.
Publicado: (2018)

Prognostic values of regulatory T cells (Tregs) and Treg-related genes in gastric cancer
por: Zheng, Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_buqvjuc384vbq0p19572ufh8lf